Physician

Akshiv Malhotra, MD

According to 2025 Medicare claims, Akshiv Malhotra, MD (NPI: 1629381819) practices hematology/oncology in the Oakland-Fremont-Berkeley, CA market, with the plurality of this provider's patient population coming from Alameda, CA. This provider's primary affiliated billing organization is UCSF MEDICAL GROUP BUSINESS SERVICES (NPI: 1477624104; TIN: 943281660) and primary practice location at 94702-2498. Malhotra is affiliated with the Aledade 147 Hill Physicians MSSP Basic E (ACO ID: A5230), participating under the MSSP model.

Malhotra's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 341 traditional Medicare patients, billed 116,149 HCPCS/CPT codes, and received $2,243,752 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 620 prescription claims across 132 beneficiaries totaling $2,173,632 in drug costs, led by Xtandi (Enzalutamide). DME data shows 46 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $143,918 to $2,243,752. Similarly, Part D prescription costs have risen steadily, from $9,602 to $2,173,632. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.1M$2.2M2016 Medicare payment: $143,918 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $858,905 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,332,419 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,828,088 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $183,950 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $939,904 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,429,200 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,834,835 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,243,752 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
201611227,497$143,918
2017264140,205$858,905
2018332124,169$1,332,419
2019352143,935$1,828,088
202011910,432$183,950
202119845,264$939,904
202225690,440$1,429,200
202335299,982$1,834,835
2024341116,149$2,243,752

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.1M$2.2M2015 Drug cost: $9,602 (USD; Tot_Drug_Cst)2016 Drug cost: $78,237 (USD; Tot_Drug_Cst)2017 Drug cost: $254,666 (USD; Tot_Drug_Cst)2018 Drug cost: $939,053 (USD; Tot_Drug_Cst)2019 Drug cost: $1,114,272 (USD; Tot_Drug_Cst)2020 Drug cost: $180,607 (USD; Tot_Drug_Cst)2021 Drug cost: $437,645 (USD; Tot_Drug_Cst)2022 Drug cost: $1,157,109 (USD; Tot_Drug_Cst)2023 Drug cost: $1,407,660 (USD; Tot_Drug_Cst)2024 Drug cost: $2,173,632 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152559$9,602
201659142$78,237
201798436$254,666
2018122788$939,053
2019123809$1,114,272
202055223$180,607
202161260$437,645
202291517$1,157,109
2023116608$1,407,660
2024132620$2,173,632

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$3.5K$7.1K2018 Medicare payment: $7,095 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $5,089 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $1,418 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/R18$7,095
2019N/R52$5,089
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/R46$1,418

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99205New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more9292$179
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more130340$155
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more120199$111
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's263593$15
36415Insertion of needle into vein for collection of blood sample117309$9

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
XtandiEnzalutamide25750$339,973
LenvimaLenvatinib Mesylate13390$310,622
JakafiRuxolitinib Phosphate12360$200,966
ImbruvicaIbrutinib12336$194,842
SprycelDasatinib11330$174,030

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
J8521Capecitabine, oral, 500 mgNN/R20$954
Q0511Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day periodNN/R14$263
Q0512Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day periodNN/R12$201

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Akshiv Malhotra, MD?

Tedicare shows public-source Medicare data for Akshiv Malhotra, MD (NPI 1629381819), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Akshiv Malhotra, MD have ACO affiliation data?

Akshiv Malhotra, MD is shown with ACO affiliation data for Aledade 147 Hill Physicians MSSP Basic E (MSSP, ACO ID A5230).

What billing organization is linked to Akshiv Malhotra, MD?

Akshiv Malhotra, MD is linked to UCSF MEDICAL GROUP BUSINESS SERVICES (billing NPI 1477624104) in the available physician profile data.

Does Akshiv Malhotra, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.